These data are consistent with the previous reports suggesting that the so-named RTK switch (loss of c-KIT/gain of c-MET) could be responsible for IM resistance of GIST T-1R cells lacking secondary KIT mutations [10,15]. The gene discussed is MET; the disease is gastrointestinal stromal tumor.